Y-C. Kim - Chonnam National University, Chonnam National University Medical School

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P2.09-08 Gefitinib Maintenance after Definitive CCRT in EGFR Mutant Stage III NSCLC: Single Arm, Open Label, Multicenter Phase 2 Trial

Y. Jang,C.-M. Choi, I.-J. Oh,Y.-C. Kim,W. Ji,J.C. Lee

Journal of Thoracic Oncology（2023）

引用0浏览0引用

1260Tip Enhancing Lung Nodule Discrimination with a Novel Cfdna Test: the Cancer Signature Ensemble (CSE) Approach

Y-C. Kim,H-J. Oh,J. Y. Park,S. H. Jang,J. Cho,Y. S. Park, Y. W. Kim, S. Y. Lee,J-K. Yoon,H-P. Kim,S. Y. Kim,T-Y. Kim

Annals of Oncology (2023): S730-S730

引用0浏览0引用

Gefitinib Maintenance After Definitive CCRT in EGFR mutant Stage III NSCLC: Single Arm, Open Label, Multicenter Phase 2 Trial

Y. Jang,C. -M. Choi, I. -J. Oh,Y. -C. Kim,W. Ji,J. C. Lee

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S334-S335

引用0浏览0引用

Clinical Response to Tepotinib According to Circulating Tumor (ct) DNA Biomarkers in Patients with Advanced NSCLC with High-Level MET Amplification (metamp) Detected by Liquid Biopsy (Lbx)

X. Le, L. G. Paz-Ares,J. Van Meerbeeck,S. Viteri,C. Cabrera-Galvez,D. V. Baz,Y. -C. Kim,J. -H. Kang,C. Stroh,D. Juraeva,R. Bruns,G. Otto,A. Johne,P. K. Paik

JOURNAL OF THORACIC ONCOLOGY（2023）

引用3浏览0引用

Korean Real-World Data on Patients with Unresectable Stage III NSCLC Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR

H. -J. Oh,C. -K. Park,Y. -C. Kim,Y. -H. Kim,S. -J. Ahn,W. G. Jeong,J. Y. Lee,J. C. Lee,C. M. Choi,W. Ji,S. Y. Song,J. Choi,S. Y. Lee,H. Kim,J. Park,S. H. Yoon,J. H. Joo, I. -J. Oh

JOURNAL OF THORACIC ONCOLOGY（2023）

引用10浏览0WOS引用

Tepotinib in Patients with Advanced NSCLC with MET Amplification (Metamp)

X. Le, R. O'Hara,L. Paz-Ares,J. P. Van Meerbeeck,S. Viteri Ramirez,C. Cabrera Galvez, D. Vincente Baz,Y. C. Kim,J. H. Kang,K. M. Schumacher,N. Karachaliou,S. Adrian,R. Bruns,P. Paik

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2022）

引用1浏览0引用

EP08.02-086 Randomized Double-blind Placebo-controlled Trial of Nicotinamide and EGFR-TKIs for EGFR-mutated Lung Adenocarcinoma

Y. -C. Kim,I. -J. Oh,C. -K. Park, H. -J. Oh,I. Y. Park, S. -C. Bae

Journal of Thoracic Oncology（2022）

引用0浏览0引用

EP08.02-142 Effects of Afatinib on the Treatment and Prognosis of Brain Metastasis in Advanced EGFR Mutation (+) NSCLC

S. Y. Lee,C. -M. Choi,Y. S. Chang, K. Y. Lee,S. J. Kim,S. H. Yang,J. S. Ryu,J. E. Lee,J. Y. Park,Y. -C. Kim,I. -J. Oh,C. Y. Jung,S. H. Lee,S. H. Yoon,J. Choi,T. W. Jang

Journal of thoracic oncologyno. 9 (2022): S471-S471

引用0浏览0引用

Lorlatinib Therapy for Rapid and Dramatic Control of Brain and Spinal Leptomeningeal Metastases from ALK-Positive Lung Adenocarcinoma

Min-Gwan Sun,In-Young Kim, Young-Jin Kim,Tae-Young Jung,Kyung-Sub Moon,Shin Jung, In-Je Oh,Young-Cheol Kim,Yoo-Duk Choi

Brain Tumor Research and Treatment（2021）

引用6浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn